|Day Low/High||45.16 / 47.48|
|52 Wk Low/High||14.56 / 57.20|
However, utilities and some technology names bucked the trend.
The S&P is putting up strong resistance that has withstood several attacks today.
Qualcomm seems to be breaking out of a bullish flag, and Celldex has a fantastic chart.
I'm content to head into the weekend with my short-term book mostly on the cash side.
Blackberry's Flying Circus, Foolish Filmmaker, Celldex Shenanigans, Benmosche's Big Mouth and Chrysler's Conundrum highlight Gregg Greenberg's list of dumb things on Wall Street this week.
Adam Feuerstein, Sr. Columnist for TheStreet, says Celldex Therapeutics is the next big thing in biotech.
Senior columnist Adam Feuerstein explains why cancer drug stocks are the next big thing in biotech.
Adam Feuerstein, senior columnist, explains why the BIO CEO Conference is the next big thing in biotech.